TELA Bio, Inc. Earnings Per Share (Diluted)
TELA Bio, Inc. (TELA) reported Earnings Per Share (Diluted) of -$0.20 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-11
- TELA Bio, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.20.
- TELA Bio, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.21.
- TELA Bio, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.17.
- TELA Bio, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.19.
- TELA Bio, Inc. earnings per share, diluted for fiscal 2025 was -$0.83.
- TELA Bio, Inc. earnings per share, diluted for fiscal 2024 was -$1.33.
- TELA Bio, Inc. earnings per share, diluted for fiscal 2023 was -$2.04.
- TELA Bio, Inc. earnings per share, diluted for fiscal 2022 was -$2.72.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.20 10-Q · filed 2026-08-11 | -$0.41 10-Q · filed 2026-08-11 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-13 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.83 10-K · filed 2026-03-25 |
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-14 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.66 10-Q · filed 2025-11-14 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.22 10-Q · filed 2026-08-11 | -$0.47 10-Q · filed 2026-08-11 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.25 10-Q · filed 2026-05-13 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-05-13 |
| 2024-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.33 10-K · filed 2026-03-25 |
| 2024-09-30 | -$0.42 10-Q · filed 2025-11-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$1.16 10-Q · filed 2025-11-14 | -$1.69 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2024-06-30 | -$0.51 10-Q · filed 2025-08-11 | -$0.74 10-Q · filed 2025-08-11 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.72 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2024-03-31 | -$0.23 10-Q · filed 2025-05-08 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2023-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.04 10-K · filed 2026-03-25 |
| 2023-09-30 | -$0.45 10-Q · filed 2024-11-08 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$1.51 10-Q · filed 2024-11-08 | -$2.03 derived: net income ÷ weighted average shares · filed 2025-03-21 |
| 2023-06-30 | -$0.46 10-Q · filed 2024-08-13 | -$1.08 10-Q · filed 2024-08-13 | -$1.60 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$2.22 derived: net income ÷ weighted average shares · filed 2025-03-21 |
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-10 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$1.78 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$2.61 derived: net income ÷ weighted average shares · filed 2025-03-21 |
| 2022-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$1.99 derived: net income ÷ weighted average shares · filed 2025-03-21 | -$2.72 10-K · filed 2025-03-21 |
| 2022-09-30 | -$0.64 10-Q · filed 2023-11-13 | -$1.50 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.24 10-Q · filed 2023-11-13 | -$2.85 derived: net income ÷ weighted average shares · filed 2024-03-22 |
| 2022-06-30 | -$0.88 10-Q · filed 2023-08-10 | -$1.62 10-Q · filed 2023-08-10 | -$2.22 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$2.79 derived: net income ÷ weighted average shares · filed 2024-03-22 |
| 2022-03-31 | -$0.75 10-Q · filed 2023-05-11 | -$1.34 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$2.48 derived: net income ÷ weighted average shares · filed 2024-03-22 |
| 2021-12-31 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$1.74 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$2.30 10-K · filed 2024-03-22 |
| 2021-09-30 | -$0.57 10-Q · filed 2022-11-10 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.71 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$0.57 10-Q · filed 2022-08-11 | -$1.13 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$0.56 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | -$2.23 10-K · filed 2023-03-23 | |||
| 2019-12-31 | -$17.10 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |